Gabriel Sosne

6PUBLICATIONS
5CO-AUTHORS
Molecular targetsOptical technologyGene and molecular therapyMedical bacteriologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 24, 2023
A Novel Combination Therapy Tβ4/VIP Protects against Hyperglycemia-Induced Changes in Human Corneal Epithelial Cells.

Abdul Shukkur Ebrahim, Thomas W Carion, Thanzeela Ebrahim

|Jan 08, 2023
0.1% RGN-259 (Thymosin ß4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial.

Gabriel Sosne, Hynda K Kleinman, Clark Springs

|Dec 24, 2021
Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection.

Yuxin Wang, Thomas W Carion, Abdul Shukkur Ebrahim

|Oct 23, 2021
Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.

Yuxin Wang, Thomas W Carion, Abdul Shukkur Ebrahim

|Sep 23, 2020
Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis.

Thomas W Carion, Abdul Shukkur Ebrahim, Spandana Alluri

|Sep 23, 2018
Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis.

Thomas W Carion, Abdul Shukkur Ebrahim, David Kracht

Pageof 1

Frequent Collaborators

5 joint publications

Elizabeth A Berger

1 joint publications

Abdul Shukkur Ebrahim

1 joint publications

Shinwook Kang

1 joint publications

Ashten Stambersky